NM_018238.4:c.841C>T

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong

The NM_018238.4(AGK):​c.841C>T​(p.Arg281*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,613,308 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000012 ( 0 hom. )

Consequence

AGK
NM_018238.4 stop_gained

Scores

3
2
2

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:3

Conservation

PhyloP100: 1.70

Publications

4 publications found
Variant links:
Genes affected
AGK (HGNC:21869): (acylglycerol kinase) The protein encoded by this gene is a mitochondrial membrane protein involved in lipid and glycerolipid metabolism. The encoded protein is a lipid kinase that catalyzes the formation of phosphatidic and lysophosphatidic acids. Defects in this gene have been associated with mitochondrial DNA depletion syndrome 10. [provided by RefSeq, Feb 2012]
AGK Gene-Disease associations (from GenCC):
  • mitochondrial disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Sengers syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • total early-onset cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • cataract 38
    Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 7-141641362-C-T is Pathogenic according to our data. Variant chr7-141641362-C-T is described in CliVar as Pathogenic. Clinvar id is 30829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-141641362-C-T is described in CliVar as Pathogenic. Clinvar id is 30829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-141641362-C-T is described in CliVar as Pathogenic. Clinvar id is 30829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-141641362-C-T is described in CliVar as Pathogenic. Clinvar id is 30829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-141641362-C-T is described in CliVar as Pathogenic. Clinvar id is 30829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-141641362-C-T is described in CliVar as Pathogenic. Clinvar id is 30829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-141641362-C-T is described in CliVar as Pathogenic. Clinvar id is 30829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-141641362-C-T is described in CliVar as Pathogenic. Clinvar id is 30829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-141641362-C-T is described in CliVar as Pathogenic. Clinvar id is 30829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-141641362-C-T is described in CliVar as Pathogenic. Clinvar id is 30829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-141641362-C-T is described in CliVar as Pathogenic. Clinvar id is 30829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-141641362-C-T is described in CliVar as Pathogenic. Clinvar id is 30829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-141641362-C-T is described in CliVar as Pathogenic. Clinvar id is 30829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-141641362-C-T is described in CliVar as Pathogenic. Clinvar id is 30829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-141641362-C-T is described in CliVar as Pathogenic. Clinvar id is 30829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-141641362-C-T is described in CliVar as Pathogenic. Clinvar id is 30829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-141641362-C-T is described in CliVar as Pathogenic. Clinvar id is 30829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-141641362-C-T is described in CliVar as Pathogenic. Clinvar id is 30829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-141641362-C-T is described in CliVar as Pathogenic. Clinvar id is 30829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-141641362-C-T is described in CliVar as Pathogenic. Clinvar id is 30829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-141641362-C-T is described in CliVar as Pathogenic. Clinvar id is 30829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-141641362-C-T is described in CliVar as Pathogenic. Clinvar id is 30829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-141641362-C-T is described in CliVar as Pathogenic. Clinvar id is 30829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-141641362-C-T is described in CliVar as Pathogenic. Clinvar id is 30829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-141641362-C-T is described in CliVar as Pathogenic. Clinvar id is 30829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGKNM_018238.4 linkc.841C>T p.Arg281* stop_gained Exon 12 of 16 ENST00000649286.2 NP_060708.1 Q53H12-1A4D1U5
AGKNM_001364948.3 linkc.841C>T p.Arg281* stop_gained Exon 12 of 15 NP_001351877.1
AGKXM_011516397.4 linkc.841C>T p.Arg281* stop_gained Exon 12 of 16 XP_011514699.1 Q53H12-1A4D1U5
AGKXM_024446835.2 linkc.841C>T p.Arg281* stop_gained Exon 12 of 16 XP_024302603.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGKENST00000649286.2 linkc.841C>T p.Arg281* stop_gained Exon 12 of 16 NM_018238.4 ENSP00000497280.1 Q53H12-1

Frequencies

GnomAD3 genomes
AF:
0.00000658
AC:
1
AN:
152074
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000799
AC:
2
AN:
250428
AF XY:
0.0000148
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000116
AC:
17
AN:
1461234
Hom.:
0
Cov.:
31
AF XY:
0.0000193
AC XY:
14
AN XY:
726918
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33426
American (AMR)
AF:
0.00
AC:
0
AN:
44578
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26084
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86140
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53402
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5756
European-Non Finnish (NFE)
AF:
0.0000126
AC:
14
AN:
1111784
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000658
AC:
1
AN:
152074
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74266
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41416
American (AMR)
AF:
0.00
AC:
0
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4804
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68014
Other (OTH)
AF:
0.00
AC:
0
AN:
2084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000151
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Sengers syndrome Pathogenic:1
Feb 10, 2012
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

not provided Pathogenic:1
Mar 13, 2017
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The R281X pathogenic variant in the AGK gene has been reported previously in two unrelated individuals with Sengers syndrome who were each compound heterozygous for the R281X variant and another loss-of-function variant (Mayr et al., 2012; Haghighi et al., 2014). This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The R281X variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret R281X as a pathogenic variant. -

Sengers syndrome;C3553494:Cataract 38 Pathogenic:1
Apr 10, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change creates a premature translational stop signal (p.Arg281*) in the AGK gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AGK are known to be pathogenic (PMID: 22284826). This variant is present in population databases (rs387907025, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with Sengers syndrome (PMID: 22284826, 25208612). ClinVar contains an entry for this variant (Variation ID: 30829). For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.62
D
BayesDel_noAF
Pathogenic
0.31
CADD
Pathogenic
38
DANN
Uncertain
1.0
Eigen
Pathogenic
0.74
Eigen_PC
Uncertain
0.58
FATHMM_MKL
Benign
0.58
D
PhyloP100
1.7
Vest4
0.93
GERP RS
5.5
Mutation Taster
=2/198
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs387907025; hg19: chr7-141341162; COSMIC: COSV62595265; API